Edition:
United States

Medistim ASA (MEDS.OL)

MEDS.OL on Oslo Stock Exchange

77.50NOK
10:18am EST
Change (% chg)

kr-0.25 (-0.32%)
Prev Close
kr77.75
Open
kr77.00
Day's High
kr78.00
Day's Low
kr77.00
Volume
1,209
Avg. Vol
24,089
52-wk High
kr84.00
52-wk Low
kr42.10

Latest Key Developments (Source: Significant Developments)

Medistim Q3 EBIT rises to NOK 15.9 million
Wednesday, 19 Oct 2016 01:55am EDT 

Medistim ASA : Q3 EBIT 15.9 million Norwegian crowns ($2 million) versus 12.7 million crowns year ago .Q3 sales ended at 67.9 million crowns (61.6 million crowns in Q3 2015), a 10.2 pct growth.  Full Article

Medistim Q2 EBIT up at NOK 17.1 million
Wednesday, 24 Aug 2016 01:55am EDT 

Medistim ASA : Q2 sales 67.2 million Norwegian crowns ($8.17 million) versus 57.3 million crowns year ago .Q2 EBIT 17.1 million crowns versus 11.7 million crowns year ago.  Full Article

Medistim's technology has achieved reimbursement in Japan
Thursday, 30 Jun 2016 04:48am EDT 

Medistim ASA : Medistim's technology has achieved reimbursement in Japan .Valid from April 1, 2016, Ministry of Health, Labour and Welfare in Japan approved a reimbursement of YEN 25,000 [EUR 225] when blood flow of the graft is controlled, using either transit time flow measurement or high-resolution epicardial ultrasonography intraoperatively.  Full Article

Medistim proposes 2015 dividend of NOK 1.65/share
Monday, 29 Feb 2016 10:14am EST 

Medistim ASA:Says ‍board suggests dividend of 1.65 Norwegian crown per share for 2015.Paid dividend of 1.40 crown per share for 2014​.  Full Article

Medistim launches its new product MiraQ in US
Friday, 22 Jan 2016 03:00am EST 

Medistim ASA:Announces that they launch its new product MiraQ in the US market.The launch takes place at the annual US Conference arranged by The Society of Thoracic Surgeons, STS, which takes place in Phoenix, Arizona, USA from the 23-27 Jan.Is seeking approval from the Ministry of Health, Labor and Welfare (MHLW) for clearance in the Japanese market and the health authorities in China, China Food and Drug Administration (CFDA) for clearance for sale in China.It is expected that these approvals will be in place by 2016.  Full Article

Blue Cap 's unit em-tec and Medistim ASA to start international cooperation
Tuesday, 27 Oct 2015 03:01am EDT 

Blue Cap AG:Subsidiary em-tec and Medistim ASA to start international cooperation.Medistim to receive from em-tec exclusive and worldwide marketing rights for products developed for non-invasive flow measurement of human blood vessels.Financial terms of contract include upfront payment of 300,000 euros and life-time minimum order of 1.4 million euros.  Full Article

Medistim ASA enters into a strategic partnership with em-tec GmbH
Thursday, 22 Oct 2015 01:10pm EDT 

Medistim ASA:Says entered into a long-term agreement with em-tec GmbH.Obtains rights to market and sell em-tec's transit time flow measurement technology for use on human blood vessels within cardiac-, vascular- and transplant surgery.Upfront payment of about 300,000 euros and minimum purchase commitments.  Full Article

Medistim introduces new specialized product for vascular surgery
Wednesday, 23 Sep 2015 03:45am EDT 

Medistim ASA:Introduces its new specialized product for vascular surgery.Medistim estimate that vascular market has an annual potential of 1 billion Norwegian crowns.  Full Article

Medistim launches MiraQ Cardiac system in Asia
Tuesday, 2 Jun 2015 08:00pm EDT 

Medistim ASA:Says Medistim is in the process of launching MiraQ Cardiac system in the Asian Market.  Full Article

Medistim ASA: Annulment of merger for Medistim second largest shareholder
Thursday, 19 Mar 2015 07:32am EDT 

Medistim ASA:Annulment of reported mother-daughter merger for Medistim second largest shareholder Salvesen & Thams Invest AS.Says boards of Salvesen & Thams Invest AS and Salvesen & Thams AS has decided that merger will not be implemented.  Full Article

BRIEF-Medistim Q3 EBIT rises to NOK 15.9 million

* Q3 EBIT 15.9 million Norwegian crowns ($2 million) versus 12.7 million crowns year ago